1. Home
  2. RANI
  3. RANI News

Latest Rani Therapeutics Holdings Inc. (RANI) News on November 18, 2025

RANI: Third Quarter Results
RANI

Zacks Small Cap Research

7 days ago

RANI: Third Quarter Results

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

11 days ago

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025
RANI

GlobeNewswire

19 days ago

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025

RANI

MT Newswires

21 days ago

Rani Therapeutics Holdings Insider Bought Shares Worth $1,260,417, According to a Recent SEC Filing

H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential
RANI

Insider Monkey

23 days ago

H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors
RANI

GlobeNewswire

25 days ago

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
RANI

GlobeNewswire

25 days ago

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

RANI

MT Newswires

a month ago

Top Premarket Gainers

RANI: Chugai Deal Announced
RANI

Zacks Small Cap Research

a month ago

RANI: Chugai Deal Announced

Rani Therapeutics (RANI): Examining Valuation After Landmark Chugai Deal and $60M Funding Boost
RANI

Simply Wall St.

a month ago

Rani Therapeutics (RANI): Examining Valuation After Landmark Chugai Deal and $60M Funding Boost

Rani Therapeutics (RANI) Is Up 257.9% After $1.08 Billion Chugai Deal and $60M Fundraise—What’s Changed
RANI

Simply Wall St.

a month ago

Rani Therapeutics (RANI) Is Up 257.9% After $1.08 Billion Chugai Deal and $60M Fundraise—What’s Changed

RANI

MT Newswires

a month ago

Top Midday Gainers

RANI

GuruFocus.com

a month ago

Why Rani Therapeutics (RANI) Stock Is Soaring Friday?

RANI

MT Newswires

a month ago

Rani Therapeutics Enters Into Up to $1.09 Billion Collaboration, License Deal With Chugai Pharmaceutical -- Shares Rise Premarket

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
RANI

GlobeNewswire

a month ago

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing
RANI

GlobeNewswire

a month ago

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

Rani Therapeutics Announces Research Agreement with Chugai
RANI

GlobeNewswire

6 months ago

Rani Therapeutics Announces Research Agreement with Chugai

RANI

Zacks Small Cap Research

6 months ago

RANI: 1Q:25 Financial Results

RANI

MT Newswires

6 months ago

Oppenheimer Adjusts Rani Therapeutics Price Target to $4 From $14, Maintains Outperform Rating

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

6 months ago

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

RANI: 2024 Financial Results
RANI

Zacks Small Cap Research

8 months ago

RANI: 2024 Financial Results

RANI

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Rani Therapeutics Holdings Inc Earnings Call

RANI

GuruFocus.com

8 months ago

Rani Therapeutics Holdings Inc (RANI) Q4 2024 Earnings Call Highlights: Navigating Financial ...

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

8 months ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102
RANI

GlobeNewswire

8 months ago

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
RANI

GlobeNewswire

8 months ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

RANI: Impressive Bioavailability for RT-116
RANI

Zacks Small Cap Research

9 months ago

RANI: Impressive Bioavailability for RT-116

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week
RANI

Simply Wall St.

9 months ago

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week

RANI

MT Newswires

9 months ago

Rani Therapeutics Discloses Progress in Oral Obesity Treatment; Shares Surge Premarket

Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
RANI

GlobeNewswire

9 months ago

Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC

RANI: Third Quarter Update
RANI

Zacks Small Cap Research

a year ago

RANI: Third Quarter Update

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

a year ago

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

Rani Therapeutics to Participate in Upcoming Investor Conferences
RANI

GlobeNewswire

a year ago

Rani Therapeutics to Participate in Upcoming Investor Conferences

Allied Gaming & Entertainment And 2 Other US Penny Stocks To Watch
RANI

Simply Wall St.

a year ago

Allied Gaming & Entertainment And 2 Other US Penny Stocks To Watch

RANI: New Triagonist Data in Weight Loss
RANI

Zacks Small Cap Research

a year ago

RANI: New Triagonist Data in Weight Loss

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
RANI

GlobeNewswire

a year ago

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

RANI

MT Newswires

a year ago

Top Midday Decliners

RANI

MT Newswires

a year ago

Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
RANI

GlobeNewswire

a year ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants

Oppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy’ Stocks
RANI

TipRanks

a year ago

Oppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy’ Stocks

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock
RANI

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
RANI

GlobeNewswire

a year ago

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

Rani Therapeutics to Participate in September Investor Conferences
RANI

GlobeNewswire

a year ago

Rani Therapeutics to Participate in September Investor Conferences

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$12m last week
RANI

Simply Wall St.

a year ago

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$12m last week

RANI

Zacks Small Cap Research

a year ago

RANI: Second Quarter Results

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

a year ago

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

RANI

MT Newswires

a year ago

Oppenheimer Initiates Rani Therapeutics Holdings at Outperform With $17 Price Target

Rani Therapeutics to Participate in August Investor Conferences
RANI

GlobeNewswire

a year ago

Rani Therapeutics to Participate in August Investor Conferences

RANI

MT Newswires

a year ago

Rani Therapeutics Prices $10 Million Registered Direct Offering

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering
RANI

GlobeNewswire

a year ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering

RANI: GLP-2 Deal Announced
RANI

Zacks Small Cap Research

a year ago

RANI: GLP-2 Deal Announced

RANI

MT Newswires

a year ago

Rani Therapeutics Partners With ProGen for Oral Obesity Treatment Development; Shares Rise

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
RANI

GlobeNewswire

a year ago

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

RANI

MT Newswires

a year ago

Maxim Starts Coverage on Rani Therapeutics With Buy Rating, $15 Price Target

RANI

MT Newswires

2 years ago

UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating

Rani Therapeutics to Participate in May Investor Conferences
RANI

GlobeNewswire

2 years ago

Rani Therapeutics to Participate in May Investor Conferences

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
RANI

GlobeNewswire

2 years ago

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

RANI: 1Q:24 Results
RANI

Zacks Small Cap Research

2 years ago

RANI: 1Q:24 Results

Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates
RANI

GuruFocus.com

2 years ago

Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

2 years ago

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

Favourable Signals For Rani Therapeutics Holdings: Numerous Insiders Acquired Stock
RANI

Simply Wall St.

2 years ago

Favourable Signals For Rani Therapeutics Holdings: Numerous Insiders Acquired Stock

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript
RANI

Insider Monkey

2 years ago

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript

RANI: 2023 Results
RANI

Zacks Small Cap Research

2 years ago

RANI: 2023 Results

RANI

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Rani Therapeutics Holdings Inc Earnings Call

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

2 years ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
RANI

GlobeNewswire

2 years ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Individual investors own 40% of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shares but private companies control 47% of the company
RANI

Simply Wall St.

2 years ago

Individual investors own 40% of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shares but private companies control 47% of the company

RANI: INITIATION – Realizing Oral Administration of Biologics
RANI

Zacks Small Cap Research

2 years ago

RANI: INITIATION – Realizing Oral Administration of Biologics

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)
RANI

GlobeNewswire

2 years ago

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)

Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics
RANI

Zacks

2 years ago

Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics

Northrim BanCorp (NASDAQ:NRIM) Is Increasing Its Dividend To $0.61
RANI

Simply Wall St.

2 years ago

Northrim BanCorp (NASDAQ:NRIM) Is Increasing Its Dividend To $0.61

Meridian Corporation Reports Fourth Quarter 2023 Results and Announces a Quarterly Dividend of $0.125 per Common Share
RANI

GlobeNewswire

2 years ago

Meridian Corporation Reports Fourth Quarter 2023 Results and Announces a Quarterly Dividend of $0.125 per Common Share

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
RANI

GlobeNewswire

2 years ago

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why
RANI

Zacks

2 years ago

Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why

IX Acquisition Corp. Announces Tenth Extension of Deadline to Complete Initial Business Combination
RANI

GlobeNewswire

2 years ago

IX Acquisition Corp. Announces Tenth Extension of Deadline to Complete Initial Business Combination

DocGo Provides Additional Information to Refute Misleading Short Seller "Report"
RANI

Business Wire

2 years ago

DocGo Provides Additional Information to Refute Misleading Short Seller "Report"

Several Insiders Invested In Community West Bancshares Flagging Positive News
RANI

Simply Wall St.

2 years ago

Several Insiders Invested In Community West Bancshares Flagging Positive News

Senseonics Holdings, Inc. Announces Business Updates
RANI

Business Wire

2 years ago

Senseonics Holdings, Inc. Announces Business Updates

Next-Gen Riches: 3 Surprising Stock Picks to Boost Your $1,000 Investment
RANI

InvestorPlace

2 years ago

Next-Gen Riches: 3 Surprising Stock Picks to Boost Your $1,000 Investment

Farmers & Merchants Bancorp, Inc. and F&M Bank Announces the Appointment of Ian D. Boyce to its Board of Directors
RANI

GlobeNewswire

2 years ago

Farmers & Merchants Bancorp, Inc. and F&M Bank Announces the Appointment of Ian D. Boyce to its Board of Directors

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
RANI

GlobeNewswire

2 years ago

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

New Strong Buy Stocks for December 13th
RANI

Zacks

2 years ago

New Strong Buy Stocks for December 13th

What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock
RANI

Zacks

2 years ago

What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock

Jean-Luc Butel Buys Handful Of Shares In Rani Therapeutics Holdings
RANI

Simply Wall St.

2 years ago

Jean-Luc Butel Buys Handful Of Shares In Rani Therapeutics Holdings

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock
RANI

Simply Wall St.

2 years ago

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock

Middlefield (MBCN) Stock Gains on Special Dividend Announcement
RANI

Zacks

2 years ago

Middlefield (MBCN) Stock Gains on Special Dividend Announcement

Independent Director of Eastern Picks Up 9.7% More Stock
RANI

Simply Wall St.

2 years ago

Independent Director of Eastern Picks Up 9.7% More Stock

RANI

GuruFocus.com

2 years ago

Rani Therapeutics Holdings Inc (RANI) Reports Q3 2023 Financial Results and Corporate Developments

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

2 years ago

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Share on Social Networks: